Furthermore, S1R agonism demonstrated synergistic neuroprotective effects when combined with the acetylcholinesterase inhibitor donepezil, the current treatment for AD, again through ROS reduction [100,124]. The gene discussed is TMBIM4; the disease is Alzheimer disease.